Takeda's Xiidra Sale: 400 Employees Join Novartis
Takeda's Xiidra Sale: 400 Employees Join Novartis in a Strategic Move In a significant development reshaping the pharmaceutical landscape, Takeda Pharmaceutical Company has finalized the sale of its
Takeda 400 Stellen
Takeda 400 Stellen — Takeda 400 Stellen
Shire Debt Strategy: Takeda Transfers 400 Xiidra Staff to Novartis
Takeda Transfers 400 Xiidra Staff to Novartis: A Strategic Debt Reduction and Portfolio Expansion The pharmaceutical industry often witnesses monumental shifts driven by mergers, acquisitions, and...
Read More →
Takeda Divests Xiidra, 400 Staffers Boost Novartis Eye Portfolio
Takeda Divests Xiidra: A Strategic Move Reshaping the Pharmaceutical Landscape In a significant maneuver within the global pharmaceutical sector, Japanese drugmaker Takeda Pharmaceutical Company has...
Read More →